WITHDRAWN: Is antioxidant activity of flavonoids mainly through the hydrogen-atom transfer mechanism?

Food Res Int

State Key Laboratory of Food Science and Technology, University of Nanchang, Nanchang 330047, China. Electronic address:

Published: November 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.foodres.2018.11.018DOI Listing

Publication Analysis

Top Keywords

withdrawn antioxidant
4
antioxidant activity
4
activity flavonoids
4
flavonoids hydrogen-atom
4
hydrogen-atom transfer
4
transfer mechanism?
4
withdrawn
1
activity
1
flavonoids
1
hydrogen-atom
1

Similar Publications

Article Synopsis
  • Natural product research has a rich history and has significantly impacted cancer treatment by targeting deregulated signaling pathways.
  • Lycium barbarum shows promise due to its antioxidant and anti-cancer properties, as demonstrated through both in vivo and in vitro studies using Ehrlich ascites tumor (EAT) cells.
  • The findings suggest that Lycium barbarum extracts reduce cancer cell adhesion and DNA damage, with the higher molecular weight extracts being more effective in promoting cancer cell death and potentially preventing cancer progression.
View Article and Find Full Text PDF

Background: Pyrazinamide is one of the antitubercular drugs used for 2 months in the intensive phase. One of the adverse effects of pyrazinamide is hyperuricemia, with a symptom of arthralgia. This study aims to analyze the incidence of hyperuricemia and arthralgia and their causality in pulmonary tuberculosis (TB) patients undergoing treatment in the intensive phase.

View Article and Find Full Text PDF

Enterolactone, coumaric acid and vitexin are polyphenolic compounds present in a variety of fruits, vegetables, cereals and plants. These bioactive compounds are in high demand due to their antioxidant property in various tissues and organs. The purpose of this study was to develop a simultaneous extraction method, an aqueous two-phase extraction (ATPE) method, that would enable the extraction of these compounds from .

View Article and Find Full Text PDF

Background: Fractional exhaled nitric oxide (FeNO) is used for the diagnosis and monitoring of asthma, although its utility to guide treatment and its correlation with other tools is still under discussion. We study the possibility to withdraw inhaled corticosteroid treatment in atopic patients with mild asthma based on the FeNO level, as well as to study its correlation with other clinical control tools.

Methods: Prospective and randomized study including atopic patients aged 18 to 65 with mild asthma, stable, on low-dose inhaled corticosteroid (ICS) treatment, who had their treatment withdrawn based on a FeNO level of 40 ppb.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!